-
1
-
-
84858308226
-
Natural products as sources of new drugs over the 30 years from 1981 to 2010
-
Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311-335.
-
(2012)
J. Nat. Prod.
, vol.75
, pp. 311-335
-
-
Newman, D.J.1
Cragg, G.M.2
-
2
-
-
58149189779
-
Drug development from marine natural products
-
Molinski, T.F.; Dalisay, D.S.; Lievens, S.L.; Saludes, J.P. Drug development from marine natural products. Nat. Rev. Drug Discov . 2009, 8, 69-85.
-
(2009)
Nat. Rev. Drug Discov
, vol.8
, pp. 69-85
-
-
Molinski, T.F.1
Dalisay, D.S.2
Lievens, S.L.3
Saludes, J.P.4
-
3
-
-
0034082239
-
The influence of natural products upon drug discovery
-
Newman, D.J.; Cragg, G.M.; Snader, K.M. The influence of natural products upon drug discovery. Nat. Prod. Rep. 2000, 17, 215-234.
-
(2000)
Nat. Prod. Rep.
, vol.17
, pp. 215-234
-
-
Newman, D.J.1
Cragg, G.M.2
Snader, K.M.3
-
4
-
-
3042617137
-
Advanced preclinical and clinical trials of natural products and related compounds from marine sources
-
Newman, D.J.; Cragg, G.M. Advanced preclinical and clinical trials of natural products and related compounds from marine sources. Curr. Med. Chem. 2004, 11, 1693-1713.
-
(2004)
Curr. Med. Chem.
, vol.11
, pp. 1693-1713
-
-
Newman, D.J.1
Cragg, G.M.2
-
5
-
-
84885627564
-
Biogeography and biodiscovery hotspots of macroalgal marine natural products
-
Leal, M.C.; Munro, M.H.; Blunt, J.W.; Puga, J.; Jesus, B.; Calado, R.; Rosa, R.; Madeira, C. Biogeography and biodiscovery hotspots of macroalgal marine natural products. Nat. Prod. Rep. 2013, 30, 1380-1390.
-
(2013)
Nat. Prod. Rep.
, vol.30
, pp. 1380-1390
-
-
Leal, M.C.1
Munro, M.H.2
Blunt, J.W.3
Puga, J.4
Jesus, B.5
Calado, R.6
Rosa, R.7
Madeira, C.8
-
6
-
-
0032993329
-
The discovery and development of marine compounds with pharmaceutical potential
-
Munro, M.H.G.; Blunt, J.W.; Dumdei, E.J.; Hickford, S.J. H.; Lill, R.E.; Li, S.X.; Battershill, C.N.; Duckworth, A.R. The discovery and development of marine compounds with pharmaceutical potential. J. Biotechnol. 1999, 70, 15-25.
-
(1999)
J. Biotechnol.
, vol.70
, pp. 15-25
-
-
Munro, M.H.G.1
Blunt, J.W.2
Dumdei, E.J.3
Hickford, S.J.H.4
Lill, R.E.5
Li, S.X.6
Battershill, C.N.7
Duckworth, A.R.8
-
7
-
-
0038461995
-
Drugs from the deep: Marine natural products as drug candidates
-
Haefner, B. Drugs from the deep: Marine natural products as drug candidates. Drug Discov. Today 2003, 8, 536-544.
-
(2003)
Drug Discov. Today
, vol.8
, pp. 536-544
-
-
Haefner, B.1
-
8
-
-
84856406381
-
Lessons from the past and charting the future of marine natural products drug discovery and chemical biology
-
Gerwick, W.H.; Moore, B.S. Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. Chem. Biol. 2012, 19, 85-98.
-
(2012)
Chem. Biol.
, vol.19
, pp. 85-98
-
-
Gerwick, W.H.1
Moore, B.S.2
-
9
-
-
77952189751
-
Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders
-
Villa, F.A.; Gerwick, L. Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders. Immunopharmacol. Immunotoxicol. 2010, 32, 228-237.
-
(2010)
Immunopharmacol. Immunotoxicol.
, vol.32
, pp. 228-237
-
-
Villa, F.A.1
Gerwick, L.2
-
10
-
-
0034142130
-
Highlights of marine natural products chemistry (1972-1999)
-
Faulkner, D.J. Highlights of marine natural products chemistry (1972-1999). Nat. Prod. Rep. 2000, 17, 1-6.
-
(2000)
Nat. Prod. Rep.
, vol.17
, pp. 1-6
-
-
Faulkner, D.J.1
-
11
-
-
67649491097
-
A renaissance in marine pharmacology: From preclinical curiosity to clinical reality
-
Glaser, K.B.; Mayer, A.M. A renaissance in marine pharmacology: From preclinical curiosity to clinical reality. Biochem. Pharmacol . 2009, 78, 440-448.
-
(2009)
Biochem. Pharmacol
, vol.78
, pp. 440-448
-
-
Glaser, K.B.1
Mayer, A.M.2
-
12
-
-
84860287730
-
Anticancer drug discovery from the marine environment
-
Nastrucci, C.; Cesario, A.; Russo, P. Anticancer drug discovery from the marine environment. Recent Pat. Anti Cancer Drug Discov . 2012, 7, 218-232.
-
(2012)
Recent Pat. Anti Cancer Drug Discov
, vol.7
, pp. 218-232
-
-
Nastrucci, C.1
Cesario, A.2
Russo, P.3
-
13
-
-
0035155735
-
Marine pharmacology in 1999: Antitumor and cytotoxic compounds
-
Mayer, A.M.; Lehmann, V.K. Marine pharmacology in 1999: Antitumor and cytotoxic compounds. Anticancer Res . 2001, 21, 2489-2500.
-
(2001)
Anticancer Res
, vol.21
, pp. 2489-2500
-
-
Mayer, A.M.1
Lehmann, V.K.2
-
14
-
-
0038219974
-
Marine pharmacology in 2000: Antitumor and cytotoxic compounds
-
Mayer, A.M.; Gustafson, K.R. Marine pharmacology in 2000: Antitumor and cytotoxic compounds. Int. J. Cancer 2003, 105, 291-299.
-
(2003)
Int. J. Cancer
, vol.105
, pp. 291-299
-
-
Mayer, A.M.1
Gustafson, K.R.2
-
15
-
-
9644278102
-
Marine pharmacology in 2001-2: Antitumour and cytotoxic compounds
-
Mayer, A.M.; Gustafson, K.R. Marine pharmacology in 2001-2: Antitumour and cytotoxic compounds. Eur. J. Cancer 2004, 40, 2676-2704.
-
(2004)
Eur. J. Cancer
, vol.40
, pp. 2676-2704
-
-
Mayer, A.M.1
Gustafson, K.R.2
-
16
-
-
33748125863
-
Marine pharmacology in 2003-2004: Anti-tumour and cytotoxic compounds
-
Mayer, A.M.; Gustafson, K.R. Marine pharmacology in 2003-2004: Anti-tumour and cytotoxic compounds. Eur. J. Cancer 2006, 42, 2241-2270.
-
(2006)
Eur. J. Cancer
, vol.42
, pp. 2241-2270
-
-
Mayer, A.M.1
Gustafson, K.R.2
-
17
-
-
54249139074
-
Marine pharmacology in 2005-2006: Antitumour and cytotoxic compounds
-
Mayer, A.M.; Gustafson, K.R. Marine pharmacology in 2005-2006: Antitumour and cytotoxic compounds. Eur. J. Cancer 2008, 44, 2357-2387.
-
(2008)
Eur. J. Cancer
, vol.44
, pp. 2357-2387
-
-
Mayer, A.M.1
Gustafson, K.R.2
-
18
-
-
78249286198
-
Antibacterials from the sea
-
Hughes, C.C.; Fenical, W. Antibacterials from the sea. Chemistry 2010, 16, 12512-12525.
-
(2010)
Chemistry
, vol.16
, pp. 12512-12525
-
-
Hughes, C.C.1
Fenical, W.2
-
19
-
-
0037865214
-
Marine natural products and their potential applications as anti-infective agents
-
Donia, M.; Hamann, M.T. Marine natural products and their potential applications as anti-infective agents. Lancet Infect. Dis. 2003, 3, 338-348.
-
(2003)
Lancet Infect. Dis.
, vol.3
, pp. 338-348
-
-
Donia, M.1
Hamann, M.T.2
-
20
-
-
77952481633
-
Novel anti-infective compounds from marine bacteria
-
Rahman, H.; Austin, B.; Mitchell, W.J.; Morris, P.C.; Jamieson, D.J.; Adams, D.R.; Spragg, A.M.; Schweizer, M. Novel anti-infective compounds from marine bacteria. Mar. Drugs 2010, 8, 498-518.
-
(2010)
Mar. Drugs
, vol.8
, pp. 498-518
-
-
Rahman, H.1
Austin, B.2
Mitchell, W.J.3
Morris, P.C.4
Jamieson, D.J.5
Adams, D.R.6
Spragg, A.M.7
Schweizer, M.8
-
21
-
-
0036024405
-
Marine pharmacology in 1999: Compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action
-
Mayer, A.M.; Hamann, M.T. Marine pharmacology in 1999: Compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2002, 132, 315-339.
-
(2002)
Comp. Biochem. Physiol. C Toxicol.Pharmacol.
, vol.132
, pp. 315-339
-
-
Mayer, A.M.1
Hamann, M.T.2
-
22
-
-
1642280223
-
Marine pharmacology in 2000: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action
-
Mayer, A.M.; Hamann, M.T. Marine pharmacology in 2000: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action. Mar. Biotechnol. 2004, 6, 37-52.
-
(2004)
Mar. Biotechnol.
, vol.6
, pp. 37-52
-
-
Mayer, A.M.1
Hamann, M.T.2
-
23
-
-
20444403434
-
Marine pharmacology in 2001-2002: Marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action
-
Mayer, A.M.; Hamann, M.T. Marine pharmacology in 2001-2002: Marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2005, 140, 265-286.
-
(2005)
Comp. Biochem. Physiol. C Toxicol.Pharmacol.
, vol.140
, pp. 265-286
-
-
Mayer, A.M.1
Hamann, M.T.2
-
24
-
-
34247550727
-
Marine pharmacology in 2003-4: Marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action
-
Mayer, A.M.; Rodriguez, A.D.; Berlinck, R.G.; Hamann, M.T. Marine pharmacology in 2003-4: Marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C Toxicol. Pharmacol . 2007, 145, 553-581.
-
(2007)
Comp. Biochem. Physiol. C Toxicol.Pharmacol.
, vol.145
, pp. 553-581
-
-
Mayer, A.M.1
Rodriguez, A.D.2
Berlinck, R.G.3
Hamann, M.T.4
-
25
-
-
67349092463
-
Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action
-
Mayer, A.M.; Rodriguez, A.D.; Berlinck, R.G.; Hamann, M.T. Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Biochim. Biophys. Acta 2009, 1790, 283-308.
-
(1790)
Biochim. Biophys. Acta 2009
, pp. 283-308
-
-
Mayer, A.M.1
Rodriguez, A.D.2
Berlinck, R.G.3
Hamann, M.T.4
-
26
-
-
78650619951
-
Marine pharmacology in 2007-2008: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action
-
Mayer, A.M.; Rodriguez, A.D.; Berlinck, R.G.; Fusetani, N. Marine pharmacology in 2007-2008: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C Toxicol. Pharmacol . 2011, 153, 191-222.
-
(2011)
Comp. Biochem. Physiol. C Toxicol.Pharmacol.
, vol.153
, pp. 191-222
-
-
Mayer, A.M.1
Rodriguez, A.D.2
Berlinck, R.G.3
Fusetani, N.4
-
27
-
-
84880913306
-
Marine pharmacology in 2009-2011: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action
-
Mayer, A.M.; Rodriguez, A.D.; Taglialatela-Scafati, O.; Fusetani, N. Marine pharmacology in 2009-2011: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mar Drugs 2013, 11, 2510-2573.
-
(2013)
Mar Drugs
, vol.11
, pp. 2510-2573
-
-
Mayer, A.M.1
Rodriguez, A.D.2
Taglialatela-Scafati, O.3
Fusetani, N.4
-
28
-
-
37049101409
-
Marine natural products: Metabolites of marine invertebrates
-
Faulkner, D.J. Marine natural products: Metabolites of marine invertebrates. Nat. Prod. Rep . 1984, 1, 551-598.
-
(1984)
Nat. Prod. Rep
, vol.1
, pp. 551-598
-
-
Faulkner, D.J.1
-
29
-
-
37049105062
-
Marine natural products: Metabolites of marine algae and herbivorous marine molluscs
-
Faulkner, D.J. Marine natural products: Metabolites of marine algae and herbivorous marine molluscs. Nat. Prod. Rep. 1984, 1, 251-280.
-
(1984)
Nat. Prod. Rep.
, vol.1
, pp. 251-280
-
-
Faulkner, D.J.1
-
30
-
-
0022666474
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1986, 3, 1-33.
-
(1986)
Nat. Prod. Rep.
, vol.3
, pp. 1-33
-
-
Faulkner, D.J.1
-
31
-
-
0023430057
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1987, 4, 539-576.
-
(1987)
Nat. Prod. Rep.
, vol.4
, pp. 539-576
-
-
Faulkner, D.J.1
-
32
-
-
0024205115
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1988, 5, 613-663.
-
(1988)
Nat. Prod. Rep.
, vol.5
, pp. 613-663
-
-
Faulkner, D.J.1
-
33
-
-
0025475193
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1990, 7, 269-309.
-
(1990)
Nat. Prod. Rep.
, vol.7
, pp. 269-309
-
-
Faulkner, D.J.1
-
34
-
-
0026149047
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1991, 8, 97-147.
-
(1991)
Nat. Prod. Rep.
, vol.8
, pp. 97-147
-
-
Faulkner, D.J.1
-
35
-
-
0000372491
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1992, 9, 323-364.
-
(1992)
Nat. Prod. Rep.
, vol.9
, pp. 323-364
-
-
Faulkner, D.J.1
-
36
-
-
0027672335
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1993, 10, 497-539.
-
(1993)
Nat. Prod. Rep.
, vol.10
, pp. 497-539
-
-
Faulkner, D.J.1
-
37
-
-
0028093929
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1994, 11, 355-394.
-
(1994)
Nat. Prod. Rep.
, vol.11
, pp. 355-394
-
-
Faulkner, D.J.1
-
38
-
-
0029107374
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1995, 12, 223-269.
-
(1995)
Nat. Prod. Rep.
, vol.12
, pp. 223-269
-
-
Faulkner, D.J.1
-
39
-
-
0030131103
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1996, 13, 75-125.
-
(1996)
Nat. Prod. Rep.
, vol.13
, pp. 75-125
-
-
Faulkner, D.J.1
-
40
-
-
0030841236
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1997, 14, 259-302.
-
(1997)
Nat. Prod. Rep.
, vol.14
, pp. 259-302
-
-
Faulkner, D.J.1
-
41
-
-
0032054664
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1998, 15, 113-158.
-
(1998)
Nat. Prod. Rep.
, vol.15
, pp. 113-158
-
-
Faulkner, D.J.1
-
42
-
-
0033118848
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1999, 16, 155-198.
-
(1999)
Nat. Prod. Rep.
, vol.16
, pp. 155-198
-
-
Faulkner, D.J.1
-
43
-
-
0034141601
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 2000, 17, 7-55.
-
(2000)
Nat. Prod. Rep.
, vol.17
, pp. 7-55
-
-
Faulkner, D.J.1
-
44
-
-
0035137292
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 2001, 18, 1-49.
-
(2001)
Nat. Prod. Rep.
, vol.18
, pp. 1-49
-
-
Faulkner, D.J.1
-
45
-
-
0036007872
-
Marine natural products
-
Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 2002, 19, 1-48.
-
(2002)
Nat. Prod. Rep.
, vol.19
, pp. 1-48
-
-
Faulkner, D.J.1
-
46
-
-
12244303632
-
Marine natural products
-
Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2003, 20, 1-48.
-
(2003)
Nat. Prod. Rep.
, vol.20
, pp. 1-48
-
-
Blunt, J.W.1
Copp, B.R.2
Munro, M.H.3
Northcote, P.T.4
Prinsep, M.R.5
-
47
-
-
1342311404
-
Marine natural products
-
Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2004, 21, 1-49.
-
(2004)
Nat. Prod. Rep.
, vol.21
, pp. 1-49
-
-
Blunt, J.W.1
Copp, B.R.2
Munro, M.H.3
Northcote, P.T.4
Prinsep, M.R.5
-
48
-
-
14844320177
-
Marine natural products
-
Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2005, 22, 15-61.
-
(2005)
Nat. Prod. Rep.
, vol.22
, pp. 15-61
-
-
Blunt, J.W.1
Copp, B.R.2
Munro, M.H.3
Northcote, P.T.4
Prinsep, M.R.5
-
49
-
-
33644973407
-
Marine natural products
-
Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2006, 23, 26-78.
-
(2006)
Nat. Prod. Rep.
, vol.23
, pp. 26-78
-
-
Blunt, J.W.1
Copp, B.R.2
Munro, M.H.3
Northcote, P.T.4
Prinsep, M.R.5
-
50
-
-
33846930947
-
Marine natural products
-
Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2007, 24, 31-86.
-
(2007)
Nat. Prod. Rep.
, vol.24
, pp. 31-86
-
-
Blunt, J.W.1
Copp, B.R.2
Hu, W.P.3
Munro, M.H.4
Northcote, P.T.5
Prinsep, M.R.6
-
51
-
-
38949180620
-
Marine natural products
-
Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2008, 25, 35-94.
-
(2008)
Nat. Prod. Rep.
, vol.25
, pp. 35-94
-
-
Blunt, J.W.1
Copp, B.R.2
Hu, W.P.3
Munro, M.H.4
Northcote, P.T.5
Prinsep, M.R.6
-
52
-
-
59449101761
-
Marine natural products
-
Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2009, 26, 170-244.
-
(2009)
Nat. Prod. Rep.
, vol.26
, pp. 170-244
-
-
Blunt, J.W.1
Copp, B.R.2
Hu, W.P.3
Munro, M.H.4
Northcote, P.T.5
Prinsep, M.R.6
-
53
-
-
76249124132
-
Marine natural products
-
Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat Prod Rep. 2010, 27, 165-237.
-
(2010)
Nat Prod Rep.
, vol.27
, pp. 165-237
-
-
Blunt, J.W.1
Copp, B.R.2
Munro, M.H.3
Northcote, P.T.4
Prinsep, M.R.5
-
54
-
-
79251496420
-
Marine natural products
-
Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2011, 28, 196-268.
-
(2011)
Nat. Prod. Rep.
, vol.28
, pp. 196-268
-
-
Blunt, J.W.1
Copp, B.R.2
Munro, M.H.3
Northcote, P.T.4
Prinsep, M.R.5
-
55
-
-
84855987293
-
Marine natural products
-
Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2012, 29, 144-222.
-
(2012)
Nat. Prod. Rep.
, vol.29
, pp. 144-222
-
-
Blunt, J.W.1
Copp, B.R.2
Keyzers, R.A.3
Munro, M.H.4
Prinsep, M.R.5
-
56
-
-
84872572982
-
Marine natural products
-
Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.; Prinsep, M.R. Marine natural products. Nat. Prod Rep. 2013, 30, 237-323.
-
(2013)
Nat. Prod Rep.
, vol.30
, pp. 237-323
-
-
Blunt, J.W.1
Copp, B.R.2
Keyzers, R.A.3
Munro, M.H.4
Prinsep, M.R.5
-
57
-
-
84892694830
-
Marine natural products
-
Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2014, 31, 160-258.
-
(2014)
Nat. Prod. Rep.
, vol.31
, pp. 160-258
-
-
Blunt, J.W.1
Copp, B.R.2
Keyzers, R.A.3
Munro, M.H.4
Prinsep, M.R.5
-
58
-
-
79955598041
-
Statistical research on marine natural products based on data obtained between 1985 and 2008
-
Hu, G.P.; Yuan, J.; Sun, L.; She, Z.G.; Wu, J.H.; Lan, X.J.; Zhu, X.; Lin, Y.C.; Chen, S.P. Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar. Drugs 2011, 9, 514-525.
-
(2011)
Mar. Drugs
, vol.9
, pp. 514-525
-
-
Hu, G.P.1
Yuan, J.2
Sun, L.3
She, Z.G.4
Wu, J.H.5
Lan, X.J.6
Zhu, X.7
Lin, Y.C.8
Chen, S.P.9
-
59
-
-
56349130803
-
Methods for isolation, purification and structural elucidation of bioactive secondary metabolites from marine invertebrates
-
Ebada, S.S.; Edrada, R.A.; Lin, W.; Proksch, P. Methods for isolation, purification and structural elucidation of bioactive secondary metabolites from marine invertebrates. Nat. Protoc . 2008, 3, 1820-1831.
-
(2008)
Nat. Protoc
, vol.3
, pp. 1820-1831
-
-
Ebada, S.S.1
Edrada, R.A.2
Lin, W.3
Proksch, P.4
-
60
-
-
34347221246
-
Monoindole alkaloids from a marine sponge Spongosorites sp
-
Bao, B.; Zhang, P.; Lee, Y.; Hong, J.; Lee, C.O.; Jung, J.H. Monoindole alkaloids from a marine sponge Spongosorites sp. Mar. Drugs 2007, 5, 31-39.
-
(2007)
Mar. Drugs
, vol.5
, pp. 31-39
-
-
Bao, B.1
Zhang, P.2
Lee, Y.3
Hong, J.4
Lee, C.O.5
Jung, J.H.6
-
61
-
-
84884678415
-
PTP1B inhibitory secondary metabolites from marine-derived fungal strains Penicillium spp. And Eurotium sp
-
Sohn, J.H.; Lee, Y.R.; Lee, D.S.; Kim, Y.C.; Oh, H. PTP1B inhibitory secondary metabolites from marine-derived fungal strains Penicillium spp. and Eurotium sp. J. Microbiol. Biotechnol. 2013, 23, 1206-1211.
-
(2013)
J. Microbiol. Biotechnol.
, vol.23
, pp. 1206-1211
-
-
Sohn, J.H.1
Lee, Y.R.2
Lee, D.S.3
Kim, Y.C.4
Oh, H.5
-
62
-
-
84905841958
-
Bioactive cembrane derivatives from the Indian Ocean soft coral, Sinularia kavarattiensis
-
Lillsunde, K.E.; Festa, C.; Adel, H.; de Marino, S.; Lombardi, V.; Tilvi, S.; Nawrot, D.A.; Zampella, A.; D'Souza, L.; D'Auria, M.V.; Tammela, P. Bioactive cembrane derivatives from the Indian Ocean soft coral, Sinularia kavarattiensis. Mar. Drugs 2014, 12, 4045-4068.
-
(2014)
Mar. Drugs
, vol.12
, pp. 4045-4068
-
-
Lillsunde, K.E.1
Festa, C.2
Adel, H.3
De Marino, S.4
Lombardi, V.5
Tilvi, S.6
Nawrot, D.A.7
Zampella, A.8
D'Souza, L.9
D'Auria, M.V.10
Tammela, P.11
-
63
-
-
0037116626
-
Evolution of anticancer drug discovery and the role of cell-based screening
-
Balis, F.M. Evolution of anticancer drug discovery and the role of cell-based screening. J. Natl. Cancer Inst. 2002, 94, 78-79.
-
(2002)
J. Natl. Cancer Inst.
, vol.94
, pp. 78-79
-
-
Balis, F.M.1
-
64
-
-
79956353002
-
Going deeper: Metagenome of a hadopelagic microbial community
-
Eloe, E.A.; Fadrosh, D.W.; Novotny, M.; Zeigler Allen, L.; Kim, M.; Lombardo, M.J.; Yee-Greenbaum, J.; Yooseph, S.; Allen, E.E.; Lasken, R.; et al. Going deeper: Metagenome of a hadopelagic microbial community. PLoS One 2011, 6, e20388.
-
(2011)
PLoS One
, vol.6
, pp. e20388
-
-
Eloe, E.A.1
Fadrosh, D.W.2
Novotny, M.3
Zeigler Allen, L.4
Kim, M.5
Lombardo, M.J.6
Yee-Greenbaum, J.7
Yooseph, S.8
Allen, E.E.9
Lasken, R.10
-
65
-
-
84861342496
-
Genomic insights to SAR86, an abundant and uncultivated marine bacterial lineage
-
Dupont, C.L.; Rusch, D.B.; Yooseph, S.; Lombardo, M.J.; Richter, R.A.; Valas, R.; Novotny, M.; Yee-Greenbaum, J.; Selengut, J.D.; Haft, D.H.; et al. Genomic insights to SAR86, an abundant and uncultivated marine bacterial lineage. ISME J. 2012, 6, 1186-1199.
-
(2012)
ISME J.
, vol.6
, pp. 1186-1199
-
-
Dupont, C.L.1
Rusch, D.B.2
Yooseph, S.3
Lombardo, M.J.4
Richter, R.A.5
Valas, R.6
Novotny, M.7
Yee-Greenbaum, J.8
Selengut, J.D.9
Haft, D.H.10
-
66
-
-
42949136443
-
Genome mining for novel natural product discovery
-
Challis, G.L. Genome mining for novel natural product discovery. J. Med. Chem. 2008, 51, 2618-2628.
-
(2008)
J. Med. Chem.
, vol.51
, pp. 2618-2628
-
-
Challis, G.L.1
-
67
-
-
0030770363
-
The natural product hymenialdisine inhibits interleukin-8 production in U937 cells by inhibition of nuclear factor-kappaB
-
Breton, J.J.; Chabot-Fletcher, M.C. The natural product hymenialdisine inhibits interleukin-8 production in U937 cells by inhibition of nuclear factor-kappaB. J. Pharmacol. Exp. Ther. 1997, 282, 459-466.
-
(1997)
J. Pharmacol. Exp. Ther.
, vol.282
, pp. 459-466
-
-
Breton, J.J.1
Chabot-Fletcher, M.C.2
-
68
-
-
0030612279
-
Inhibition of NFkappaB-mediated interleukin-1beta-stimulated prostaglandin E2 formation by the marine natural product hymenialdisine
-
Roshak, A.; Jackson, J.R.; Chabot-Fletcher, M.; Marshall, L.A. Inhibition of NFkappaB-mediated interleukin-1beta-stimulated prostaglandin E2 formation by the marine natural product hymenialdisine. J. Pharmacol. Exp. Ther. 1997, 283, 955-961.
-
(1997)
J. Pharmacol. Exp. Ther.
, vol.283
, pp. 955-961
-
-
Roshak, A.1
Jackson, J.R.2
Chabot-Fletcher, M.3
Marshall, L.A.4
-
69
-
-
0034010742
-
Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent
-
Meijer, L.; Thunnissen, A.M.; White, A.W.; Garnier, M.; Nikolic, M.; Tsai, L.H.; Walter, J.; Cleverley, K.E.; Salinas, P.C.; Wu, Y.Z.; et al . Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent. Chem. Biol. 2000, 7, 51-63.
-
(2000)
Chem. Biol.
, vol.7
, pp. 51-63
-
-
Meijer, L.1
Thunnissen, A.M.2
White, A.W.3
Garnier, M.4
Nikolic, M.5
Tsai, L.H.6
Walter, J.7
Cleverley, K.E.8
Salinas, P.C.9
Wu, Y.Z.10
-
70
-
-
0001006448
-
Isolation and X-ray crystal structure of a novel bromo-compound from two marine sponges
-
Cimino, G.; de Rosa, S.; de Stefano, S.; Mazzarella, L.; Puliti, R.; Sodano, G. Isolation and X-ray crystal structure of a novel bromo-compound from two marine sponges. Tetrahedron Lett. 1982, 23, 767-768.
-
(1982)
Tetrahedron Lett.
, vol.23
, pp. 767-768
-
-
Cimino, G.1
De Rosa, S.2
De Stefano, S.3
Mazzarella, L.4
Puliti, R.5
Sodano, G.6
-
71
-
-
70249101414
-
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: Results of a randomized phase II study of two different schedules
-
Demetri, G.D.; Chawla, S.P.; von Mehren, M.; Ritch, P.; Baker, L.H.; Blay, J.Y.; Hande, K.R.; Keohan, M.L.; Samuels, B.L.; Schuetze, S.; et al. Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: Results of a randomized phase II study of two different schedules. J. Clin. Oncol. 2009, 27, 4188-4196.
-
(2009)
J. Clin. Oncol.
, vol.27
, pp. 4188-4196
-
-
Demetri, G.D.1
Chawla, S.P.2
Von Mehren, M.3
Ritch, P.4
Baker, L.H.5
Blay, J.Y.6
Hande, K.R.7
Keohan, M.L.8
Samuels, B.L.9
Schuetze, S.10
-
72
-
-
77955505177
-
A review of trabectedin (ET-743): A unique mechanism of action
-
D'Incalci, M.; Galmarini, C.M. A review of trabectedin (ET-743): A unique mechanism of action. Mol. Cancer Ther. 2010, 9, 2157-2163.
-
(2010)
Mol. Cancer Ther.
, vol.9
, pp. 2157-2163
-
-
D'Incalci, M.1
Galmarini, C.M.2
-
73
-
-
77952921894
-
Wide-spectrum characterization of trabectedin: Biology, clinical activity and future perspectives
-
Vincenzi, B.; Napolitano, A.; Frezza, A.M.; Schiavon, G.; Santini, D.; Tonini, G. Wide-spectrum characterization of trabectedin: Biology, clinical activity and future perspectives. Pharmacogenomics 2010, 11, 865-878.
-
(2010)
Pharmacogenomics
, vol.11
, pp. 865-878
-
-
Vincenzi, B.1
Napolitano, A.2
Frezza, A.M.3
Schiavon, G.4
Santini, D.5
Tonini, G.6
-
74
-
-
84866736948
-
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis
-
Monk, B.J.; Herzog, T.J.; Kaye, S.B.; Krasner, C.N.; Vermorken, J.B.; Muggia, F.M.; Pujade-Lauraine, E.; Park, Y.C.; Parekh, T.V.; Poveda, A.M. Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis. Eur. J. Cancer 2012, 48, 2361-2368.
-
(2012)
Eur. J. Cancer
, vol.48
, pp. 2361-2368
-
-
Monk, B.J.1
Herzog, T.J.2
Kaye, S.B.3
Krasner, C.N.4
Vermorken, J.B.5
Muggia, F.M.6
Pujade-Lauraine, E.7
Park, Y.C.8
Parekh, T.V.9
Poveda, A.M.10
-
75
-
-
84877297872
-
13 years of trabectedin, 5 years of Yondelis(R): What have we learnt?
-
Le Cesne, A. 13 years of trabectedin, 5 years of Yondelis(R): What have we learnt? Expert Rev. Anticancer Ther. 2013, 13, 11-19.
-
(2013)
Expert Rev. Anticancer Ther.
, vol.13
, pp. 11-19
-
-
Le Cesne, A.1
-
76
-
-
84904358530
-
Clinical utility of trabectedin for the treatment of ovarian cancer: Current evidence
-
Mascilini, F.; Amadio, G.; di Stefano, M.G.; Ludovisi, M.; di Legge, A.; Conte, C.; de Vincenzo, R.; Ricci, C.; Masciullo, V.; Salutari, V.; et al. Clinical utility of trabectedin for the treatment of ovarian cancer: Current evidence. Onco Targets Ther. 2014, 7, 1273-1284.
-
(2014)
Onco Targets Ther.
, vol.7
, pp. 1273-1284
-
-
Mascilini, F.1
Amadio, G.2
Di Stefano, M.G.3
Ludovisi, M.4
Di Legge, A.5
Conte, C.6
De Vincenzo, R.7
Ricci, C.8
Masciullo, V.9
Salutari, V.10
-
77
-
-
84863272116
-
Natural products as kinase inhibitors
-
Liu, J.; Hu, Y.; Waller, D.L.; Wang, J.; Liu, Q. Natural products as kinase inhibitors. Nat. Prod. Rep. 2012, 29, 392-403.
-
(2012)
Nat. Prod. Rep.
, vol.29
, pp. 392-403
-
-
Liu, J.1
Hu, Y.2
Waller, D.L.3
Wang, J.4
Liu, Q.5
-
78
-
-
84879193645
-
Natural peptides with potential applications in drug development, diagnosis, and/or biotechnology
-
2012
-
Hayashi, M.A.; Ducancel, F.; Konno, K. Natural peptides with potential applications in drug development, diagnosis, and/or biotechnology. Int. J. Pept. 2012, 2012, doi:10.1155/2012/757838.
-
(2012)
Int. J. Pept.
-
-
Hayashi, M.A.1
Ducancel, F.2
Konno, K.3
-
79
-
-
84883256420
-
Future directions for peptide therapeutics development
-
Kaspar, A.A.; Reichert, J.M. Future directions for peptide therapeutics development. Drug Discov. Today 2013, 18, 807-817.
-
(2013)
Drug Discov. Today
, vol.18
, pp. 807-817
-
-
Kaspar, A.A.1
Reichert, J.M.2
-
80
-
-
0033810234
-
An evaluation of intrathecal ziconotide for the treatment of chronic pain
-
Jain, K.K. An evaluation of intrathecal ziconotide for the treatment of chronic pain. Expert Opin. Investig. Drugs 2000, 9, 2403-2410.
-
(2000)
Expert Opin. Investig. Drugs
, vol.9
, pp. 2403-2410
-
-
Jain, K.K.1
-
82
-
-
17544377633
-
Matemone, a new bioactive bromine-containing oxindole alkaloid from the indian ocean sponge Iotrochota purpurea
-
Carletti, I.; Banaigs, B.; Amade, P. Matemone, a new bioactive bromine-containing oxindole alkaloid from the indian ocean sponge Iotrochota purpurea. J. Nat. Prod. 2000, 63, 981-983.
-
(2000)
J. Nat. Prod.
, vol.63
, pp. 981-983
-
-
Carletti, I.1
Banaigs, B.2
Amade, P.3
-
83
-
-
0033758451
-
Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula
-
Milligan, K.E.; Marquez, B.L.; Williamson, R.T.; Gerwick, W.H. Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2000, 63, 1440-1443.
-
(2000)
J. Nat. Prod.
, vol.63
, pp. 1440-1443
-
-
Milligan, K.E.1
Marquez, B.L.2
Williamson, R.T.3
Gerwick, W.H.4
-
84
-
-
0033765654
-
Isolation and structure of the cytotoxin lyngbyabellin B and absolute configuration of lyngbyapeptin A from the marine cyanobacterium Lyngbya majuscula
-
Luesch, H.; Yoshida, W.Y.; Moore, R.E.; Paul, V.J. Isolation and structure of the cytotoxin lyngbyabellin B and absolute configuration of lyngbyapeptin A from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2000, 63, 1437-1439.
-
(2000)
J. Nat. Prod.
, vol.63
, pp. 1437-1439
-
-
Luesch, H.1
Yoshida, W.Y.2
Moore, R.E.3
Paul, V.J.4
-
85
-
-
0016476488
-
Impact of the national cancer act on grant support
-
Kalberer, J.T., Jr. Impact of the national cancer act on grant support. Cancer Res . 1975, 35, 472-481.
-
(1975)
Cancer Res
, vol.35
, pp. 472-481
-
-
Kalberer, J.T.1
-
86
-
-
80054720218
-
The role of funding and policies on innovation in cancer drug development
-
Kanavos, P.; Sullivan, R.; Lewison, G.; Schurer, W.; Eckhouse, S.; Vlachopioti, Z. The role of funding and policies on innovation in cancer drug development. Ecancermedicalscience 2010, 4, doi:10.3332/ecancer.2010.164.
-
(2010)
Ecancermedicalscience
, vol.4
-
-
Kanavos, P.1
Sullivan, R.2
Lewison, G.3
Schurer, W.4
Eckhouse, S.5
Vlachopioti, Z.6
-
87
-
-
9444249285
-
National cooperative drug discovery groups (NCDDGs): A successful model for public private partnerships in cancer drug discovery
-
Hallock, Y.F.; Cragg, G.M. National cooperative drug discovery groups (NCDDGs): A successful model for public private partnerships in cancer drug discovery. Pharm. Biol. 2003, 41, 78-91.
-
(2003)
Pharm. Biol.
, vol.41
, pp. 78-91
-
-
Hallock, Y.F.1
Cragg, G.M.2
-
88
-
-
70450227226
-
The roche research institute of marine pharmacology, 1974-1981: Searching for drug Leads from Australian Marine Organisms
-
Rae, I.D. The roche research institute of marine pharmacology, 1974-1981: Searching for drug Leads from Australian Marine Organisms. Hist. Rec. Aust. Sci. 2009, 20, 209-231.
-
(2009)
Hist. Rec. Aust. Sci.
, vol.20
, pp. 209-231
-
-
Rae, I.D.1
-
89
-
-
0003155576
-
The NCI In vitro anticancer drug discovery screen
-
1st ed.; Teicher, B. Humana Press: Totowa, NJ, USA
-
st ed.; Teicher, B., Ed.; Humana Press: Totowa, NJ, USA, 1997; pp. 23-42.
-
(1997)
Anticancer Drug Development Guide
, pp. 23-42
-
-
Boyd, M.1
-
90
-
-
0018944539
-
Drugs from marine organisms: The target of the Roche Research Institute of Marine Pharmacology in Australia
-
Von Berlepsch, K. Drugs from marine organisms: The target of the Roche Research Institute of Marine Pharmacology in Australia. Naturwissenschaften 1980, 67, 338-342.
-
(1980)
Naturwissenschaften
, vol.67
, pp. 338-342
-
-
Von Berlepsch, K.1
-
91
-
-
33749011163
-
The NCI60 human tumour cell line anticancer drug screen
-
Shoemaker, R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 2006, 6, 813-823.
-
(2006)
Nat. Rev. Cancer
, vol.6
, pp. 813-823
-
-
Shoemaker, R.H.1
-
92
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
-
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
-
(1983)
J. Immunol. Methods
, vol.65
, pp. 55-63
-
-
Mosmann, T.1
-
93
-
-
0023792919
-
Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines
-
Scudiero, D.A.; Shoemaker, R.H.; Paull, K.D.; Monks, A.; Tierney, S.; Nofziger, T.H.; Currens, M.J.; Seniff, D.; Boyd, M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988, 48, 4827-4833.
-
(1988)
Cancer Res.
, vol.48
, pp. 4827-4833
-
-
Scudiero, D.A.1
Shoemaker, R.H.2
Paull, K.D.3
Monks, A.4
Tierney, S.5
Nofziger, T.H.6
Currens, M.J.7
Seniff, D.8
Boyd, M.R.9
-
94
-
-
0025341331
-
New colorimetric cytotoxicity assay for anticancer-drug screening
-
Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J.T.; Bokesch, H.; Kenney, S.; Boyd, M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
-
(1990)
J. Natl. Cancer Inst.
, vol.82
, pp. 1107-1112
-
-
Skehan, P.1
Storeng, R.2
Scudiero, D.3
Monks, A.4
McMahon, J.5
Vistica, D.6
Warren, J.T.7
Bokesch, H.8
Kenney, S.9
Boyd, M.R.10
-
95
-
-
0034043334
-
Aminosterols from the dogfish shark Squalus acanthias
-
Rao, M.N.; Shinnar, A.E.; Noecker, L.A.; Chao, T.L.; Feibush, B.; Snyder, B.; Sharkansky, I.; Sarkahian, A.; Zhang, X.; Jones, S.R.; et al. Aminosterols from the dogfish shark Squalus acanthias. J. Nat. Prod. 2000, 63, 631-635.
-
(2000)
J. Nat. Prod.
, vol.63
, pp. 631-635
-
-
Rao, M.N.1
Shinnar, A.E.2
Noecker, L.A.3
Chao, T.L.4
Feibush, B.5
Snyder, B.6
Sharkansky, I.7
Sarkahian, A.8
Zhang, X.9
Jones, S.R.10
-
96
-
-
0033945101
-
Antineoplastic agents 430. Isolation and structure of cribrostatins 3, 4, and 5 from the republic of maldives cribrochalina species
-
Pettit, G.R.; Knight, J.C.; Collins, J.C.; Herald, D.L.; Pettit, R.K.; Boyd, M.R.; Young, V.G. Antineoplastic agents 430. Isolation and structure of cribrostatins 3, 4, and 5 from the republic of maldives cribrochalina species. J. Nat. Prod. 2000, 63, 793-798.
-
(2000)
J. Nat. Prod.
, vol.63
, pp. 793-798
-
-
Pettit, G.R.1
Knight, J.C.2
Collins, J.C.3
Herald, D.L.4
Pettit, R.K.5
Boyd, M.R.6
Young, V.G.7
-
97
-
-
0034865734
-
New bromoditerpenes from the red alga Sphaerococcus coronopifolius
-
Etahiri, S.; Bultel-Ponce, V.; Caux, C.; Guyot, M. New bromoditerpenes from the red alga Sphaerococcus coronopifolius. J. Nat. Prod. 2001, 64, 1024-1027.
-
(2001)
J. Nat. Prod.
, vol.64
, pp. 1024-1027
-
-
Etahiri, S.1
Bultel-Ponce, V.2
Caux, C.3
Guyot, M.4
-
98
-
-
0035200190
-
Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge
-
Cueto, M.; Jensen, P.R.; Kauffman, C.; Fenical, W.; Lobkovsky, E.; Clardy, J. Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge. J. Nat. Prod. 2001, 64, 1444-1446.
-
(2001)
J. Nat. Prod.
, vol.64
, pp. 1444-1446
-
-
Cueto, M.1
Jensen, P.R.2
Kauffman, C.3
Fenical, W.4
Lobkovsky, E.5
Clardy, J.6
-
99
-
-
84905919391
-
Confronting the challenges of discovery of novel antibacterial agents
-
Singh, S.B. Confronting the challenges of discovery of novel antibacterial agents. Bioorg. Med. Chem. Lett . 2014, 24, 3683-3689.
-
(2014)
Bioorg. Med. Chem. Lett
, vol.24
, pp. 3683-3689
-
-
Singh, S.B.1
-
100
-
-
78751477224
-
Challenges of antibacterial discovery
-
Silver, L.L. Challenges of antibacterial discovery. Clin. Microbiol. Rev. 2011, 24, 71-109.
-
(2011)
Clin. Microbiol. Rev.
, vol.24
, pp. 71-109
-
-
Silver, L.L.1
-
101
-
-
0034727834
-
Managing antibiotic resistance
-
Wenzel, R.P.; Edmond, M.B. Managing antibiotic resistance. N. Engl. J. Med. 2000, 343, 1961-1963.
-
(2000)
N. Engl. J. Med.
, vol.343
, pp. 1961-1963
-
-
Wenzel, R.P.1
Edmond, M.B.2
-
102
-
-
0035713533
-
Neonatal bacteremia: Patterns of antibiotic resistance
-
Bromiker, R.; Arad, I.; Peleg, O.; Preminger, A.; Engelhard, D. Neonatal bacteremia: Patterns of antibiotic resistance. Infect. Control Hosp. Epidemiol . 2001, 22, 767-770.
-
(2001)
Infect. Control Hosp. Epidemiol
, vol.22
, pp. 767-770
-
-
Bromiker, R.1
Arad, I.2
Peleg, O.3
Preminger, A.4
Engelhard, D.5
-
103
-
-
84901207664
-
Antimicrobial resistance: A global challenge
-
Howard, S.J.; Hopwood, S.; Davies, S.C. Antimicrobial resistance: A global challenge. Sci. Transl. Med. 2014, 6, 236ed10.
-
(2014)
Sci. Transl. Med.
, vol.6
, pp. 236ed10
-
-
Howard, S.J.1
Hopwood, S.2
Davies, S.C.3
-
104
-
-
15544384259
-
Antibacterial drug discovery: Is it all downhill from here?
-
Projan, S.J.; Shlaes, D.M. Antibacterial drug discovery: Is it all downhill from here? Clin. Microbiol. Infect. 2004, 10, 18-22.
-
(2004)
Clin. Microbiol. Infect.
, vol.10
, pp. 18-22
-
-
Projan, S.J.1
Shlaes, D.M.2
-
105
-
-
0242291985
-
Why is big Pharma getting out of antibacterial drug discovery?
-
Projan, S.J. Why is big Pharma getting out of antibacterial drug discovery? Curr. Opin. Microbiol. 2003, 6, 427-430.
-
(2003)
Curr. Opin. Microbiol.
, vol.6
, pp. 427-430
-
-
Projan, S.J.1
-
106
-
-
69549111337
-
Antibiotics for emerging pathogens
-
Fischbach, M.A.; Walsh, C.T. Antibiotics for emerging pathogens. Science 2009, 325, 1089-1093.
-
(2009)
Science
, vol.325
, pp. 1089-1093
-
-
Fischbach, M.A.1
Walsh, C.T.2
-
107
-
-
84886542459
-
Drug discovery for neglected diseases: Molecular target-based and phenotypic approaches
-
Gilbert, I.H. Drug discovery for neglected diseases: Molecular target-based and phenotypic approaches. J. Med. Chem. 2013, 56, 7719-7726.
-
(2013)
J. Med. Chem.
, vol.56
, pp. 7719-7726
-
-
Gilbert, I.H.1
-
108
-
-
0038155163
-
Biofilm-specific cross-species induction of antimicrobial compounds in bacilli
-
Yan, L.M.; Boyd, K.G.; Adams, D.R.; Burgess, J.G. Biofilm-specific cross-species induction of antimicrobial compounds in bacilli. Appl. Environ. Microbiol. 2003, 69, 3719-3727.
-
(2003)
Appl. Environ. Microbiol.
, vol.69
, pp. 3719-3727
-
-
Yan, L.M.1
Boyd, K.G.2
Adams, D.R.3
Burgess, J.G.4
-
109
-
-
79954431143
-
Cross-species induction of antimicrobial compounds, biosurfactants and quorum-sensing inhibitors in tropical marine epibiotic bacteria by pathogens and biofouling microorganisms
-
Dusane, D.H.; Matkar, P.; Venugopalan, V.P.; Kumar, A.R.; Zinjarde, S.S. Cross-Species Induction of Antimicrobial Compounds, Biosurfactants and Quorum-Sensing Inhibitors in Tropical Marine Epibiotic Bacteria by Pathogens and Biofouling Microorganisms. Curr. Microbiol. 2011, 62, 974-980.
-
(2011)
Curr. Microbiol.
, vol.62
, pp. 974-980
-
-
Dusane, D.H.1
Matkar, P.2
Venugopalan, V.P.3
Kumar, A.R.4
Zinjarde, S.S.5
-
110
-
-
79959811774
-
Bacterial symbionts and natural products
-
Crawford, J.M.; Clardy, J. Bacterial symbionts and natural products. Chem. Commun. 2011, 47, 7559-7566.
-
(2011)
Chem. Commun.
, vol.47
, pp. 7559-7566
-
-
Crawford, J.M.1
Clardy, J.2
-
112
-
-
84893928918
-
Diversity, abundance and natural products of marine sponge-associated actinomycetes
-
Abdelmohsen, U.R.; Bayer, K.; Hentschel, U. Diversity, abundance and natural products of marine sponge-associated actinomycetes. Nat. Prod. Rep. 2014, 31, 381-399.
-
(2014)
Nat. Prod. Rep.
, vol.31
, pp. 381-399
-
-
Abdelmohsen, U.R.1
Bayer, K.2
Hentschel, U.3
-
113
-
-
78049442273
-
Immense essence of excellence: Marine microbial bioactive compounds
-
Bhatnagar, I.; Kim, S.K. Immense essence of excellence: Marine microbial bioactive compounds. Mar. Drugs 2010, 8, 2673-2701.
-
(2010)
Mar. Drugs
, vol.8
, pp. 2673-2701
-
-
Bhatnagar, I.1
Kim, S.K.2
-
114
-
-
33646056420
-
Drug discovery from natural sources
-
Chin, Y.W.; Balunas, M.J.; Chai, H.B.; Kinghorn, A.D. Drug discovery from natural sources. AAPS J. 2006, 8; E239-E253.
-
(2006)
AAPS J.
, vol.8
, pp. E239-E253
-
-
Chin, Y.W.1
Balunas, M.J.2
Chai, H.B.3
Kinghorn, A.D.4
-
115
-
-
63049120723
-
Actinomycetes for marine drug discovery isolated from mangrove soils and plants in China
-
Hong, K.; Gao, A.H.; Xie, Q.Y.; Gao, H.; Zhuang, L.; Lin, H.P.; Yu, H.P.; Li, J.; Yao, X.S.; Goodfellow, M.; et al. Actinomycetes for marine drug discovery isolated from mangrove soils and plants in China. Mar. Drugs 2009, 7, 24-44.
-
(2009)
Mar. Drugs
, vol.7
, pp. 24-44
-
-
Hong, K.1
Gao, A.H.2
Xie, Q.Y.3
Gao, H.4
Zhuang, L.5
Lin, H.P.6
Yu, H.P.7
Li, J.8
Yao, X.S.9
Goodfellow, M.10
-
117
-
-
47949096781
-
Cancer-related inflammation
-
Mantovani, A.; Allavena, P.; Sica, A.; Balkwill, F. Cancer-related inflammation. Nature 2008, 454, 436-444.
-
(2008)
Nature
, vol.454
, pp. 436-444
-
-
Mantovani, A.1
Allavena, P.2
Sica, A.3
Balkwill, F.4
-
118
-
-
49149125924
-
Immunotherapy for neurological diseases
-
Villoslada, P.; Moreno, B.; Melero, I.; Pablos, J.L.; Martino, G.; Uccelli, A.; Montalban, X.; Avila, J.; Rivest, S.; Acarin, L.; et al. Immunotherapy for neurological diseases. Clin. Immunol. 2008, 128, 294-305.
-
(2008)
Clin. Immunol.
, vol.128
, pp. 294-305
-
-
Villoslada, P.1
Moreno, B.2
Melero, I.3
Pablos, J.L.4
Martino, G.5
Uccelli, A.6
Montalban, X.7
Avila, J.8
Rivest, S.9
Acarin, L.10
-
119
-
-
80052498659
-
Marine natural products: A new wave of drugs?
-
Montaser, R.; Luesch, H. Marine natural products: A new wave of drugs? Future Med. Chem. 2011, 3, 1475-1489.
-
(2011)
Future Med. Chem.
, vol.3
, pp. 1475-1489
-
-
Montaser, R.1
Luesch, H.2
|